ClinConnect ClinConnect Logo
Search / Trial NCT03142022

Sleep-disordered Breathing After Solid Organ Transplantation

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · May 2, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating sleep-disordered breathing (SDB) in patients who have received a lung transplant. SDB is when a person stops breathing for short periods during sleep, which can lead to daytime tiredness and affect their quality of life. As more people live longer after organ transplants, understanding how SDB impacts them has become increasingly important, especially since many experience weight gain and other health issues that could worsen sleep problems.

To participate in this study, you must be at least one year post-lung transplant and be willing to undergo a sleep study called polysomnography (PSG), which measures your sleep patterns. The trial is open to both men and women aged 65 to 74. If you choose to join, you'll help researchers learn more about how SDB affects lung transplant patients, which may lead to better care and treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 1 year after lung transplantation
  • Exclusion Criteria:
  • Refusal of PSG
  • Medical contra-indication to perform PSG

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Leuven, , Belgium

Patients applied

0 patients applied

Trial Officials

Dries Testelmans, MD, PhD

Principal Investigator

UZ Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials